Table 2.
Disease | Applicability | Ref 1 |
---|---|---|
Atopic dermatitis | Diagnostic marker, response marker, severity marker | [34,69] |
Asthma | Diagnostic marker, severity marker, marker for exacerbation | [33,70] |
Drug eruption | Severity marker | [71] |
Chronic rhinitis | Characterize disease phenotype | [72] |
IgG4-related disease | Role in pathogenesis | [73] |
Alopecia areata | Disease activity and response marker | [74] |
Generalized pustular psoriasis | Therapeutic response marker | [75] |
Chronic obstructive pulmonary disease | Marker for decrease lung function | [76,77] |
Ankylosing spondylitis | Role in pathogenesis | [78] |
Acute eosinophilic pneumonia | Diagnostic marker | [79] |
Bullous pemphigoid | Role in pathogenesis | [80] |
Food protein-induced enterocolitis syndrome | Diagnostic marker | [81] |
Bronchopulmonary Aspergillosis in cystic fibrosis | Diagnostic marker | [82] |
Cutaneous lupus erythematosus | Role in pathogenesis | [83] |
Systemic lupus erythematosus | Role in pathogenesis | [35] |
1 Ref: Reference.